| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 179,023 | 189,072 | 220,177 | 162,982 | | Cost of Revenue | 163,783 | 169,671 | 178,269 | 145,603 | | | Gross Profit | 15,240 | 19,401 | 41,908 | 17,379 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 8,491 | 7,687 | 7,709 | 6,378 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 6,749 | 11,714 | 34,199 | 11,001 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 4,054 | 2,911 | (512) | (3,307) | | Earnings Before Interest And Taxes | 10,803 | 14,625 | 33,687 | 7,694 | | Interest Expense | 3,181 | 3,535 | 3,505 | 1,833 | | Income Before Tax | 7,622 | 11,090 | 30,182 | 5,861 | | Income Tax Expense | 2,542 | 4,451 | 12,130 | 2,104 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 5,080 | 6,639 | 18,052 | 3,757 | | | Non-recurring Events | | Discontinued Operations | 23 | 157 | 129 | (184) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 5,103 | 6,796 | 18,181 | 3,573 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $5,103 | $6,796 | $18,181 | $3,573 |
|
0.51% Nasdaq 
Income Statement
